MX2016006643A - Composicion para prevenir infeccion por mycoplasma spp. - Google Patents

Composicion para prevenir infeccion por mycoplasma spp.

Info

Publication number
MX2016006643A
MX2016006643A MX2016006643A MX2016006643A MX2016006643A MX 2016006643 A MX2016006643 A MX 2016006643A MX 2016006643 A MX2016006643 A MX 2016006643A MX 2016006643 A MX2016006643 A MX 2016006643A MX 2016006643 A MX2016006643 A MX 2016006643A
Authority
MX
Mexico
Prior art keywords
curing
preventing
composition
mycoplasma infection
vaccine
Prior art date
Application number
MX2016006643A
Other languages
English (en)
Other versions
MX368864B (es
Inventor
Jiunn-Horng Lin
Perng WANG Jyh-
Weng CHEN Zeng-
Yu Fang Chien-
Wei HSIEH Ming-
Cheng Yang Ping-
Original Assignee
Agricultural Tech Res Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agricultural Tech Res Inst filed Critical Agricultural Tech Res Inst
Publication of MX2016006643A publication Critical patent/MX2016006643A/es
Publication of MX368864B publication Critical patent/MX368864B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/164—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/70—Vectors or expression systems specially adapted for E. coli

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

Se proporciona una proteína que se usa como ingrediente activo para una vacuna de subunidad contra el micoplasma y la vacuna preparada con la misma; la vacuna comprende P46, Tuf o proteína compuesta de los mismos, y también puede comprender MHP30, NrdFC o proteína compuesta de los mismos.
MX2016006643A 2013-11-21 2013-11-21 Composicion para prevenir infeccion por mycoplasma spp. MX368864B (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CN2013/087599 WO2015074213A1 (zh) 2013-11-21 2013-11-21 防治霉浆菌感染的组合物

Publications (2)

Publication Number Publication Date
MX2016006643A true MX2016006643A (es) 2017-01-16
MX368864B MX368864B (es) 2019-10-18

Family

ID=53178807

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2016006643A MX368864B (es) 2013-11-21 2013-11-21 Composicion para prevenir infeccion por mycoplasma spp.

Country Status (14)

Country Link
US (2) US9951109B2 (es)
EP (1) EP3072523B1 (es)
JP (1) JP6434017B2 (es)
KR (1) KR101842081B1 (es)
CN (2) CN105792841B (es)
BR (1) BR112016010427B1 (es)
DK (1) DK3072523T3 (es)
ES (1) ES2714000T3 (es)
MX (1) MX368864B (es)
PH (1) PH12016500946A1 (es)
RU (1) RU2646137C2 (es)
TW (1) TWI615402B (es)
UA (1) UA116697C2 (es)
WO (1) WO2015074213A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9951109B2 (en) * 2013-11-21 2018-04-24 Agricultural Technology Research Institute Composition for preventing Mycoplasma spp. infection
WO2018027526A1 (zh) * 2016-08-09 2018-02-15 财团法人农业科技研究院 防治猪鼻霉浆菌感染的组合物及生产该组合物的方法
TWI606839B (zh) * 2016-08-09 2017-12-01 財團法人農業科技研究院 防治豬鼻黴漿菌感染之組合物及生產該組合物的方法
WO2019084833A1 (zh) * 2017-11-01 2019-05-09 财团法人农业科技研究院 防治家禽滑膜霉浆菌感染的组合物
CN110904138A (zh) * 2018-09-17 2020-03-24 杭州博茵生物技术有限公司 一种Msyb融合标签的大肠杆菌可溶性蛋白表达载体、构建方法及应用
CN112485423A (zh) * 2020-11-16 2021-03-12 江苏省农业科学院 一种通用的猪支原体抗原含量快速检测试剂盒及其应用
CN114853910A (zh) * 2022-05-19 2022-08-05 福建省农业科学院畜牧兽医研究所 一种具有免疫原性的绵羊肺炎支原体hsp70-p113融合蛋白

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0475185A1 (en) * 1990-08-27 1992-03-18 Nippon Flour Mills Co., Ltd. DNA's encoding surface antigen of mycoplasma hyopneumoniae, DNA fragments for primer, recombinant antigenic peptides and diagnostic method of mycoplasmal pneumoniae of swine using same
JPH06172213A (ja) * 1992-05-31 1994-06-21 Uen Chun-Nan マイコプラズマ肺炎用ワクチン
AU6128900A (en) 1999-09-29 2001-04-05 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mph3 gene and uses thereof
CA2340455A1 (en) * 2001-03-28 2002-09-28 Pfizer Products Inc. Nucleic acids and proteins of the mycoplasma hyopneumoniae mhp3 gene and uses thereof
BR0211049A (pt) 2001-07-02 2004-07-20 Pfizer Prod Inc Método de tratamento ou prevenção de doenças ou disfunções e uso de mycoplasma hyopneumoniae
DK2027873T3 (en) * 2001-07-02 2015-11-09 Zoetis Services Llc Single Dose Vaccination with Mycoplasma hyopneumoniae
WO2006056841A1 (en) * 2004-11-24 2006-06-01 Pharmacia & Upjohn Company Llc Multiple-strain mycoplasma hyopneumoniae vaccines
JP2006311824A (ja) * 2005-05-09 2006-11-16 National Agriculture & Food Research Organization 豚マイコプラズマ肺炎ワクチン
CN102732473B (zh) * 2011-04-08 2017-03-15 华中农业大学 表达猪肺炎支原体p46蛋白的重组猪霍乱沙门氏菌及制备方法与应用
UA114504C2 (uk) * 2012-04-04 2017-06-26 Зоетіс Сервісіз Ллс Комбінована вакцина pcv, mycoplasma hyopneumoniae та prrs
US9120859B2 (en) * 2012-04-04 2015-09-01 Zoetis Services Llc Mycoplasma hyopneumoniae vaccine
BR112015018444A2 (pt) * 2013-02-05 2018-05-08 Agricultural Technology Research Institute composição para prevenir infecção de mycoplasma spp., e vetor de expressão
US9951109B2 (en) * 2013-11-21 2018-04-24 Agricultural Technology Research Institute Composition for preventing Mycoplasma spp. infection

Also Published As

Publication number Publication date
US10059749B2 (en) 2018-08-28
EP3072523B1 (en) 2018-12-26
DK3072523T3 (en) 2019-04-08
CN110302368B (zh) 2022-11-04
ES2714000T3 (es) 2019-05-24
KR101842081B1 (ko) 2018-03-26
US9951109B2 (en) 2018-04-24
CN110302368A (zh) 2019-10-08
JP2016538846A (ja) 2016-12-15
MX368864B (es) 2019-10-18
RU2646137C2 (ru) 2018-03-01
CN105792841B (zh) 2019-07-26
EP3072523A4 (en) 2017-05-03
US20160264631A1 (en) 2016-09-15
WO2015074213A1 (zh) 2015-05-28
WO2015074213A8 (zh) 2016-05-19
BR112016010427B1 (pt) 2020-06-02
RU2016123841A (ru) 2017-12-26
TWI615402B (zh) 2018-02-21
PH12016500946A1 (en) 2016-06-27
EP3072523A1 (en) 2016-09-28
TW201520222A (zh) 2015-06-01
JP6434017B2 (ja) 2018-12-05
BR112016010427A2 (pt) 2017-12-05
US20180208629A1 (en) 2018-07-26
CN105792841A (zh) 2016-07-20
KR20160060771A (ko) 2016-05-30
UA116697C2 (uk) 2018-04-25

Similar Documents

Publication Publication Date Title
PH12016500946A1 (en) Composition for preventing and curing mycoplasma infection
EP3505620A4 (en) 2D ORGANOID FOR INFECTIONS AND GROWTH OF HUMAN DIARRHOEVIRUS AND USE OF THE TWO-DIMENSIONAL ORGANOID
AU2018243910A8 (en) A multiple antigen presenting system (MAPS)-based staphylococcus aureus vaccine, immunogenic composition, and uses thereof
NI201500135A (es) Composición farmacéutica de hidrocloruro de s-ketamina
MX2016008448A (es) Conjugados de var2csa-farmaco.
MX2015012342A (es) Composición farmacéutica de clorhidrato de s-cetamina.
WO2015023649A3 (en) Peptides for enhancing transdermal delivery
PH12015501888A1 (en) Novel bacteriophage and antibacterial composition comprising the same
TW201144301A (en) Processes for preparing linezolid
EP3878445A3 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
CL2015001772A1 (es) Composición farmacéutica para el tratamiento de dolor cabeza, y método de preparación de la misma.
TWD190432S (zh) 鼻管
BR112016014880A2 (pt) Composição farmacêutica incluindo palonosetron
PH12016500465B1 (en) Deoxynojirimycin derivatives and methods of their using
PH12015501716B1 (en) Anti-mycoplasma spp. subunit vaccine
EA032927B1 (ru) Производные гидроксиалкилпиперазина в качестве модуляторов cxcr3 рецептора
MX363530B (es) Compuesto de benzoxaborol tricíclico, método de preparación y uso del mismo.
MX2017012596A (es) Una composicion farmaceutica y el uso de la misma.
EP3541419A4 (en) IMMUNOGENIC COMPOSITION FOR MERS CORONAVIRUS INFECTION
IN2013MU01985A (es)
MX2018005035A (es) Formulaciones de liberacion sostenida de anestesicos locales.
MX2016007224A (es) Vacuna contra el circovirus porcino tipo 2.
MX2018005350A (es) Formulacion de combinacion de dosis fija, eflornitina y sulindaco.
BR112018016715A2 (pt) ?formulações de oritavancina?
MX350718B (es) Vacuna de rinitis equina.

Legal Events

Date Code Title Description
FG Grant or registration